Filing Details
- Accession Number:
- 0001562180-15-000634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-04 11:32:07
- Reporting Period:
- 2015-08-03
- Filing Date:
- 2015-08-04
- Accepted Time:
- 2015-08-04 11:32:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237564 | M Steven Paul | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-08-03 | 4,822 | $67.98 | 718,828 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 9,158 | $67.05 | 709,670 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-03 | 6,020 | $66.42 | 703,650 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $67.60 USD to $68.595 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $66.62 USD to $67.59 USD. The price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $66.00 USD to $66.58 USD. The price reported above reflects the weighted average sale price.
Billionaire Hedge Funds
